Read More 3 minute read Movers 12 Health Care Stocks Moving In Thursday’s Intraday Session By Benzinga Insights June 8, 1:32 PM Gainers ThermoGenesis Holdings (NASDAQ:THMO) shares moved upwards by 21.1% to $1.49 during Thursday’s regular session. Trading volume for… ACRX
Read More 3 minute read Options Stocks That Hit 52-Week Lows On Wednesday By Benzinga Insights June 7, 12:38 PM On Wednesday, 29 companies set new 52-week lows. AWH
Read More 14 minute read Options Stocks That Hit 52-Week Lows On Wednesday By Benzinga Insights May 31, 1:04 PM During Wednesday's session, 212 companies made new 52-week lows. AA
Read More 1 minute read Movers 12 Health Care Stocks Moving In Monday’s Pre-Market Session By Benzinga Insights May 29, 9:06 AM Gainers Elevation Oncology (NASDAQ:ELEV) shares rose 89.4% to $5.7 during Monday’s pre-market session. The company’s market cap stands… EFTR
Read More 15 minute read Options Stocks That Hit 52-Week Lows On Thursday By Benzinga Insights May 25, 1:22 PM On Thursday, 221 companies hit new 52-week lows. AA
Read More 6 minute read Options Stocks That Hit 52-Week Lows On Monday By Benzinga Insights May 22, 12:08 PM On Monday, 85 stocks hit new 52-week lows. ADMP
Read More 2 minute read Management News Gamida Cell Appoints Terry Coelho As CFO, Effective Immediately By Benzinga Newsdesk May 22, 8:05 AM Industry veteran Coelho brings more than 35 years of experience at emerging growth and global companies to role; Shai Lankry to leave company June 2Gamida Cell Ltd. (NASDAQ:GMDA), a cell therapy pioneer working to turn FWBI
Read More 5 minute read Options Stocks That Hit 52-Week Lows On Friday By Benzinga Insights May 19, 1:59 PM On Friday, 63 companies hit new 52-week lows. AGIL
Read More 2 minute read Analyst Ratings Expert Ratings for First Wave BioPharma By Benzinga Insights May 15, 11:01 AM Over the past 3 months, 4 analysts have published their opinion on First Wave BioPharma (NASDAQ:FWBI) stock. These… FWBI
Read More 2 minute read Analyst Ratings 5 Analysts Have This to Say About First Wave BioPharma By Benzinga Insights April 26, 5:01 PM Within the last quarter, First Wave BioPharma (NASDAQ:FWBI) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent… FWBI